Visalytics
Visalytics
approved EB-2 (NIW)

Post-Doctoral Fellow

Molecular Biology · Turkey · 2025-11-19

Processing Time
568 days
Decision Date
2025-11-19
Location
Michigan
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to discover new biomarkers for cancer, neurodegenerative diseases, metabolic disorders, and inflammatory conditions by analyzing molecular irregularities in biological samples. This work involves developing refined methods for identifying disease-associated molecular signatures to enable earlier detection and innovative therapeutic strategies, such as hormone-based and immune-based treatments.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor addresses escalating burdens on U.S. public health systems by improving diagnostic and therapeutic approaches for cancer and neurodegenerative diseases.

2 Well-positioned to Advance the Endeavor Met

The petitioner's Ph.D., publication record in high-impact journals, and 138 citations demonstrate the necessary expertise and influence in the field.

3 On Balance, Beneficial to Waive Job Offer Met

The petitioner's unique contributions to biomarker discovery and early disease detection provide benefits that outweigh the need for labor certification.

Why This Petition Was Approved

The petition was approved based on the petitioner's Ph.D. in Neuroscience and a record of 4 peer-reviewed journal articles, 10 abstracts, and 1 preprint, which collectively earned 138 citations. Evidence also included one completed peer review and four expert recommendation letters affirming the national importance of the research. The case successfully satisfied all three prongs of the Dhanasar framework.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Independent
Judging Experience
Original Contributions

Similar Cases

Postdoctoral Researcher

Biotechnology · China

WeGreened EB-2 (NIW) approved
Texas 106 days 2022-05-04
The petitioner proposes to continue her research in disease genetics and cellular therapeutics, specifically investigating stem cell-based cancer therapeutics and developing functional biomarkers for cancer treatment. Her work focuses on determining the mechanisms underpinning the development of cancer and neurodegenerative diseases to reduce their global impact.
View Case

Postdoctoral Researcher

Biotechnology · China

WeGreened EB-2 (NIW) rfe approved
New Jersey 103 days 2025-07-17
The petitioner proposes to continue characterizing the genetic, molecular, and biological mechanisms underlying complex diseases such as cancer, neuronal disorders, and psychiatric conditions. Her work integrates bioinformatics, multi-omics analysis, and artificial intelligence with wet-lab validation to support early detection and personalized medical strategies.
View Case

Director

Healthcare · Turkey

WeGreened EB-2 (NIW) approved
Georgia 6 days 2023-10-02
The petitioner proposes to continue her research in translational pathology, specifically examining biobank data to investigate underlying cancer mechanisms. Her work focuses on identifying novel biomarkers to improve diagnostics, treatments, and patient outcomes for various forms of cancer.
View Case

Scientist

Biotechnology · China

WeGreened EB-2 (NIW) approved
New Jersey 6 days 2024-10-10
The petitioner proposes to develop advanced statistical models using real-world evidence and omics data to identify novel biomarkers for diseases. This work aims to facilitate the development of precision drug therapies and enhance the understanding of cancer, metabolic disorders, and cardiovascular diseases.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from Turkey

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-11-19.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 568 days
Criteria Met 3 / 3
Evidence Types 5

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in Turkey All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist